Felipe Cancino-Galvez

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Subclonal immune evasion in non-small cell lung cancer.

Subclonal immune evasion in non-small cell lung cancer.

Journal: Cancer cell

Published: May 19, 2026

Engineering and Improving Anti-CTLA-4 Checkpoint Inhibitors.

Engineering and Improving Anti-CTLA-4 Checkpoint Inhibitors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 07, 2026

NK cell mechanosensing through CD16a.

NK cell mechanosensing through CD16a.

Journal: Nature reviews. Immunology

Published: March 30, 2026

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

Journal: British journal of cancer

Published: February 04, 2026

DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.

DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.

Journal: Oncoimmunology

Published: January 11, 2026

Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody Development.

Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody Development.

Journal: Annual review of medicine

Published: November 13, 2025

Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic.

Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic.

Journal: Journal for immunotherapy of cancer

Published: September 13, 2025

Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic.

Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic.

Journal: Journal for immunotherapy of cancer

Published: September 13, 2025

Facts and Hopes in Harnessing Macrophage-Mediated Antibody-Dependent Cellular Phagocytosis for Cancer Immunotherapy.

Facts and Hopes in Harnessing Macrophage-Mediated Antibody-Dependent Cellular Phagocytosis for Cancer Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 22, 2025

The Dark Side of NK Cells in Cancer Immunotherapy.

The Dark Side of NK Cells in Cancer Immunotherapy.

Journal: Cancer discovery

Published: July 06, 2025

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.

Journal: Immunity

Published: May 30, 2025

Subclonal immune evasion in non-small cell lung cancer.

Subclonal immune evasion in non-small cell lung cancer.

Journal: Cancer cell

Published: June 15, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026